TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 78 filers reported holding TRINITY BIOTECH PLC in Q1 2016. The put-call ratio across all filers is 5.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 239 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | -66.7% | 239 | -53.0% | 0.00% | – |
| Q1 2018 | $3,000 | 0.0% | 509 | 0.0% | 0.00% | – |
| Q4 2017 | $3,000 | +50.0% | 509 | +88.5% | 0.00% | – |
| Q3 2017 | $2,000 | 0.0% | 270 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 270 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | 0.0% | 270 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | -50.0% | 270 | 0.0% | 0.00% | – |
| Q3 2016 | $4,000 | +33.3% | 270 | 0.0% | 0.00% | – |
| Q2 2016 | $3,000 | 0.0% | 270 | 0.0% | 0.00% | – |
| Q4 2015 | $3,000 | – | 270 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STONEHILL CAPITAL MANAGEMENT LLC | 3,002,572 | $3,303,000 | 1.09% |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 1,558,900 | $1,715,000 | 0.66% |
| Fondren Management LP | 230,000 | $253,000 | 0.64% |
| Invenomic Capital Management LP | 401,019 | $441,000 | 0.36% |
| Paradice Investment Management LLC | 1,543,115 | $1,697,000 | 0.16% |
| HEARTLAND ADVISORS INC | 885,300 | $974,000 | 0.10% |
| Renaissance Technologies | 874,225 | $962,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 12,781 | $14,000 | 0.00% |
| ATWOOD & PALMER INC | 100 | $0 | 0.00% |
| TWO SIGMA ADVISERS, LP | 30,500 | $34,000 | 0.00% |